S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Gross Profit Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Gross Profit
kr574.3m
CAGR 3-Years
70%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Gross Profit
kr6.8B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Gross Profit
kr484m
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
14%
Getinge AB
STO:GETI B
Gross Profit
kr14.5B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Gross Profit
kr4.7B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Gross Profit
kr206.1m
CAGR 3-Years
45%
CAGR 5-Years
26%
CAGR 10-Years
22%

See Also

What is Surgical Science Sweden AB's Gross Profit?
Gross Profit
574.3m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Gross Profit amounts to 574.3m SEK.

What is Surgical Science Sweden AB's Gross Profit growth rate?
Gross Profit CAGR 5Y
61%

Over the last year, the Gross Profit growth was -5%. The average annual Gross Profit growth rates for Surgical Science Sweden AB have been 70% over the past three years , 61% over the past five years .

Back to Top